In patients receiving ICAM immediately after diagnosis, the success rate is 96.4%
A cocktail of drugs against Covid-19 is being tested on patients at a hospital in Florida, us United States. The compound of remedies, according to the creators, has a positive result in more than 95% of cases if applied early in the development of the disease. ICAM, as the therapy was called, is composed of vitamins and zinc, corticosteroids, anticoagulants and antibiotics, according to the health entity. Altogether, 100 people who tested positive for the coronavirus test volunteered to be treated with the drugs outside the hospital as part of a clinical trial supported by the Florida Department of Health and the Florida Heart Health Center, the specialist website said. “TrialSite News”.
ICAM was developed by the pharmacy board and a team of doctors at Ocala hospital and has been provided to people hospitalized by Covid-19 for months. The compound has not yet been tested in mild cases of infection, but in hospitalized patients. “For 76 days, our patients had zero transfers to the intensive care unit, zero need for mechanical ventilators and zero deaths from treatments like ICAM or similar,” said Adventette Health director of pharmacy Ocala, Carlette Norwood-Williams. She noted that research shows that with the right medication applied immediately after diagnosis, a patient can have a better response, regardless of age or other conditions, and this increases their chances of survival. In patients who receive ICAM immediately after diagnosis, the success rate is 96.4%, according to Norwood-Williams and colleagues. The purpose of the clinical trial is to determine whether the work of the team of specialists at the Ocala hospital can be used elsewhere to try to reduce mortality rate Covid-19.
*With EFE Agency